跳转至内容
Merck
CN

J4455

JSH-23

≥98% (HPLC), NF-kB nuclear translocation inhibitor, solid

别名:

4-甲基-N1-(3-苯基丙基)-1,2-苯二胺

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C16H20N2
化学文摘社编号:
分子量:
240.34
UNSPSC Code:
51111800
NACRES:
NA.77
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

JSH-23, ≥98% (HPLC), solid

SMILES string

N(CCCc2ccccc2)c1c(cc(cc1)C)N

InChI

1S/C16H20N2/c1-13-9-10-16(15(17)12-13)18-11-5-8-14-6-3-2-4-7-14/h2-4,6-7,9-10,12,18H,5,8,11,17H2,1H3

InChI key

YMFNPBSZFWXMAD-UHFFFAOYSA-N

assay

≥98% (HPLC)

form

solid

storage condition

protect from light

color

off-white to gray-pink

solubility

DMSO: >10 mg/mL

shipped in

wet ice

storage temp.

−20°C

Quality Level

Application

JSH-23 已被用作一种核因子 κB(NF-κB)p65 抑制剂。

Biochem/physiol Actions

JSH-23 是一种 NF-κB 核易位抑制剂。
JSH-23 是一种 NF-κB 核易位抑制剂。EMSA 和蛋白质印迹分析表明,它抑制 LPS 和细胞因子诱导的 NF-kB p65 亚基的核易位过程。该化合物具有适度的抑制活性(RAW 264.7 细胞中 IC50 值为 7.1 uM),但不影响 IkB 降解或恢复。该化合物以剂量依赖性方式抑制 LPS 诱导的细胞因子、COX2 和 iNOS 的表达,并且可能结合或干扰 p65 的和定位信号(NLS)。

Other Notes

光和空气敏感。

存储类别

11 - Combustible Solids

wgk

WGK 3

pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Acute Tox. 4 Oral - Skin Sens. 1B


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

HMGB1 promotes the activation of NLRP3 and caspase-8 inflammasomes via NF-?B pathway in acute glaucoma.
Chi W et al.
Journal of Neuroinflammation, 12, 137-137 (2015)
Macrophage TCF-4 co-activates p65 to potentiate chronic inflammation and insulin resistance in mice.
Kang X et al.
Clinical Science (London, England : 1979), 130, 1257-1257 (2016)
L Shi et al.
Oncogene, 36(12), 1631-1643 (2016-11-22)
The coordination between cellular differentiation and the mesenchymal/stem transition is essential for both embryo development and neoplasia, suggesting a mechanistic link between these two major processes. In this work we show that miR-127, an embryo-expressing lung miRNA, was prominently induced
Xia Kang et al.
Clinical science (London, England : 1979), 130(14), 1257-1268 (2016-04-30)
Transcription factor 4 (TCF-4) was recently identified as a candidate gene for the cause of type 2 diabetes, although the mechanisms have not been fully elucidated. In the present study, we demonstrated that the TCF-4 transgene in macrophages aggravated high-fat diet
Meibao Feng et al.
Molecular cancer, 15(1), 77-77 (2016-12-04)
Lipocalin2 (LCN2) is a secretory protein that is aberrantly expressed in several types of cancer and has been involved in metastatic progression. However, neither mechanisms nor the role that LCN2 plays in the metastasis of colorectal cancer are clear. LCN2

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持